Mackenzie Financial’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,925
| Closed | -$237K | – | 1574 |
|
|
2023
Q2 | $237K | Sell |
4,925
-129
| -3% | -$6.21K | ﹤0.01% | 1264 |
|
|
2023
Q1 | $212K | Sell |
5,054
-193
| -4% | -$8.1K | ﹤0.01% | 1326 |
|
|
2022
Q4 | $200K | Sell |
5,247
-169
| -3% | -$6.45K | ﹤0.01% | 1252 |
|
|
2022
Q3 | $212K | Buy |
+5,416
| New | +$212K | ﹤0.01% | 1224 |
|
|
2022
Q2 | – | Sell |
-49,146
| Closed | -$1.63M | – | 1531 |
|
|
2022
Q1 | $1.63M | Sell |
49,146
-1,100
| -2% | -$36.4K | ﹤0.01% | 790 |
|
|
2021
Q4 | $2.14M | Buy |
50,246
+1,300
| +3% | +$55.3K | ﹤0.01% | 758 |
|
|
2021
Q3 | $2.17M | Buy |
48,946
+9,400
| +24% | +$417K | ﹤0.01% | 740 |
|
|
2021
Q2 | $2.25M | Buy |
39,546
+16,400
| +71% | +$932K | ﹤0.01% | 698 |
|
|
2021
Q1 | $1.73M | Buy |
+23,146
| New | +$1.73M | ﹤0.01% | 710 |
|
|
2020
Q1 | – | Sell |
-8,573
| Closed | -$619K | – | 1163 |
|
|
2019
Q4 | $619K | Buy |
8,573
+8
| +0.1% | +$578 | ﹤0.01% | 821 |
|
|
2019
Q3 | $1.2M | Buy |
8,565
+71
| +0.8% | +$9.96K | ﹤0.01% | 694 |
|
|
2019
Q2 | $1.56M | Buy |
8,494
+1,997
| +31% | +$366K | ﹤0.01% | 678 |
|
|
2019
Q1 | $1.03M | Buy |
6,497
+3,734
| +135% | +$594K | ﹤0.01% | 914 |
|
|
2018
Q4 | $265K | Sell |
2,763
-14,412
| -84% | -$1.38M | ﹤0.01% | 1050 |
|
|
2018
Q3 | $2.43M | Buy |
17,175
+1,486
| +9% | +$210K | 0.01% | 612 |
|
|
2018
Q2 | $2.46M | Buy |
15,689
+13,576
| +642% | +$2.13M | 0.01% | 567 |
|
|
2018
Q1 | $340K | Buy |
+2,113
| New | +$340K | ﹤0.01% | 792 |
|